Literature DB >> 18768489

Mortality among HIV-1- and human herpesvirus type 8-affected mother-infant pairs in Zambia.

Janet Wojcicki1, Mulindi Mwanahamuntu, Veenu Minhas, Boris Djokic, Chipepo Kankasa, Winslow Klaskala, Brad Brayfield, Saul Phiri, Charles Wood, Charles D Mitchell.   

Abstract

OBJECTIVE: To determine the respective trends in mortality of Zambian mother-infant pairs based on maternal infection with HIV-1 and human herpesvirus type 8 (HHV-8).
METHODS: A prospective cohort study was done on Zambian mother-infant pairs, stratified by maternal serologic status and followed from 6 weeks postdelivery for 48 months. Statistical analysis of the differences in the calculated mortality rates among the four groups was done using Stata 7.0. Kaplan-Meier analysis and Cox proportional hazard models were used to measure subject survival time.
RESULTS: Between September 1998 and March 2002, a total of 1,425 mother-infant pairs were enrolled. The crude mortality rate among children born to dually infected mothers was approximately 9 times higher (245.90 deaths per 1,000 live births) when compared with the death ratio of children born to seronegative mothers (24.63 deaths per 1,000 live births). The incidence rate for death was 0.34/1,000 in infants of co-infected mothers in comparison with 0.32/1,000 among HIV-1-infected mothers, 0.0336/1,000 among uninfected mothers, and 0.0403/1,000 among HHV-8-infected mothers (chi(2) = 154.56; P < 0.01). Infants of co-infected mothers had a comparable risk of death in comparison with infants infected with HIV-1 alone [hazard ratio, 9.91 [95% confidence interval (95% CI), 5.08-19.37] for co-infected versus 9.26 [95% CI, 4.75-18.07] for HIV-1-infected alone]. Infants of mothers infected only with HHV-8 also had comparable survival in comparison with uninfected infants (hazard ratio, 1.21; 95% CI, 0.56-2.61).
CONCLUSION: Infants born to mothers dually infected with both HIV-1 and HHV-8 have comparable survival with infants exposed to HIV-1 alone. Infants born to mothers infected only with HHV-8 have comparable survival with uninfected infants.

Entities:  

Mesh:

Year:  2008        PMID: 18768489      PMCID: PMC2892478          DOI: 10.1158/1055-9965.EPI-08-0254

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  35 in total

1.  Increasing probability of mother-to-child transmission of HHV-8 with increasing maternal antibody titer for HHV-8.

Authors:  F Sitas; R Newton; C Boshoff
Journal:  N Engl J Med       Date:  1999-06-17       Impact factor: 91.245

2.  Natural history of human immunodeficiency virus type 1 infection in children: a five-year prospective study in Rwanda. Mother-to-Child HIV-1 Transmission Study Group.

Authors:  R Spira; P Lepage; P Msellati; P Van De Perre; V Leroy; A Simonon; E Karita; F Dabis
Journal:  Pediatrics       Date:  1999-11       Impact factor: 7.124

3.  The global HIV and AIDS epidemic, 2001.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2001-06-01       Impact factor: 17.586

4.  Water, socioeconomic factors, and human herpesvirus 8 infection in Ugandan children and their mothers.

Authors:  Sam M Mbulaiteye; Robert J Biggar; Ruth M Pfeiffer; Paul M Bakaki; Christine Gamache; Anchilla M Owor; Edward Katongole-Mbidde; Christopher M Ndugwa; James J Goedert; Denise Whitby; Eric A Engels
Journal:  J Acquir Immune Defic Syndr       Date:  2005-04-01       Impact factor: 3.731

5.  Routine care of people with HIV infection and AIDS: should interested general practitioners take the lead?

Authors:  S Singh; A Dunford; Y H Carter
Journal:  Br J Gen Pract       Date:  2001-05       Impact factor: 5.386

6.  Risk factors for human herpesvirus 8 seropositivity and seroconversion in a cohort of homosexual men.

Authors:  N H Dukers; N Renwick; M Prins; R B Geskus; T F Schulz; G J Weverling; R A Coutinho; J Goudsmit
Journal:  Am J Epidemiol       Date:  2000-02-01       Impact factor: 4.897

7.  Kaposi's sarcoma-associated herpesvirus serology in Europe and Uganda: multicentre study with multiple and novel assays.

Authors:  O Schatz; P Monini; R Bugarini; F Neipel; T F Schulz; M Andreoni; P Erb; M Eggers; J Haas; S Buttò; M Lukwiya; J R Bogner; S Yaguboglu; J Sheldon; L Sarmati; F D Goebel; R Hintermaier; G Enders; N Regamey; M Wernli; M Stürzl; G Rezza; B Ensoli
Journal:  J Med Virol       Date:  2001-09       Impact factor: 2.327

8.  Healthy life expectancy in 191 countries, 1999.

Authors:  C D Mathers; R Sadana; J A Salomon; C J Murray; A D Lopez
Journal:  Lancet       Date:  2001-05-26       Impact factor: 79.321

9.  Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection. Italian Register for HIV Infection in Children and the Italian National AIDS Registry.

Authors:  M de Martino; P A Tovo; M Balducci; L Galli; C Gabiano; G Rezza; P Pezzotti
Journal:  JAMA       Date:  2000-07-12       Impact factor: 56.272

10.  Seroprevalence of human herpesvirus 8 among Zambian women of childbearing age without Kaposi's sarcoma (KS) and mother-child pairs with KS.

Authors:  J He; G Bhat; C Kankasa; C Chintu; C Mitchell; W Duan; C Wood
Journal:  J Infect Dis       Date:  1998-12       Impact factor: 5.226

View more
  1 in total

Review 1.  HHV-8 Seroprevalence and Genotype Distribution in Africa, 1998⁻2017: A Systematic Review.

Authors:  Elizabeth M Etta; Doyinmola P Alayande; Lufuno G Mavhandu-Ramarumo; George Gachara; Pascal O Bessong
Journal:  Viruses       Date:  2018-08-27       Impact factor: 5.048

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.